Innovative Cleanroom Technologies completes 17,000 sqft cleanroom


Akron Biotech chose ICT for the design, manufacture, and build of its ISO Class 7 cleanroom

Innovative Cleanroom Technologies (ICT) has completed a Design-Manufacture-Build of a 17,000-sqft cleanroom project for Akron Biotech in Sarasota, Florida.

This project was completed on time and within budget.

ICT is a specialist in cleanroom technology in Binghamton, New York. Its manufacturing plant produces industry-leading modular cleanroom walls and walkable ceiling systems designed to create ultrapure environments for countless different applications.

The Akron Biotech cleanroom is designed to meet cGMP and FDA standards for manufacturing pharmaceuticals and biologics. It features Class 10,000 (ISO 7) air quality and includes aseptic filling capabilities.

The Akron Biotech cleanroom is designed to meet cGMP and FDA standards for manufacturing pharmaceuticals and biologics

ICT provides cleanroom solutions that meet or exceed the most stringent international standards, including ISO 14644-1 and FED 209E. Its modular wall and ceiling systems are designed for maximum durability and ease of installation, while its USP 797/800 sterile compounding solutions provide a complete turnkey solution for critical environment needs. In addition, ICT offers a full range of accessories and installation services to ensure cleanrooms meet the highest standards of quality and performance.

A key component of any successful ICT turnkey solution is the ability to accept and be accountable for the performance and cost of an entire project.

Like this story? Subscribe to Cleanroom Technology magazine for incisive analysis of the latest news and developments in hi-tech industries manufacturing in controlled environments.

"At ICT, we believe that a truly comprehensive approach means fully understanding all aspects of a cleanroom facility project and overseeing every stage of its design, construction and commissioning. This includes taking on the responsibility for ensuring that the project meets all of its specified requirements in terms of cost, quality and performance," said ICT President M. Ronald Harms. "By working closely with our clients to identify their specific needs and challenges, we can provide customised solutions that deliver measurable results."

Sign up for your free email newsletter

"We would like to thank Akron Biotech for its confidence in us, and we look forward to continuing our partnership with them. ICT is committed to excellence and quality, and this project represents a new benchmark for us in terms of the level of service we can provide," Harms added.